<h3>Gainers</h3>
<ul>
<li>Liminatus Pharma (NASDAQ:LIMN) stock increased by 28.5% to $0.73 during Tuesday's pre-market session. The company's market cap stands at $15.4 million. </li>
<li>CDT Equity (NASDAQ:CDT) stock increased by 15.31% to $1.28. The market value of their outstanding shares is at $2.5 million. </li>
<li>DaVita (NYSE:DVA) stock moved upwards by 10.63% to $123.02. The company's market cap stands at $7.8 billion. As per the news, the Q4 earnings report came out yesterday. </li>
<li>GT Biopharma (NASDAQ:GTBP) stock rose 10.13% to $0.56. The market value of their outstanding shares is at $13.6 million. </li>
<li>Evotec (NASDAQ:EVO) shares moved upwards by 9.35% to $3.74. The market value of their outstanding shares is at $1.2 billion. </li>
<li>Autonomix Medical (NASDAQ:AMIX) shares increased by 8.17% to $0.44. The company's market cap stands at $2.7 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Armata Pharmaceuticals (AMEX:ARMP) stock decreased by 28.4% to $5.54 during Tuesday's pre-market session. The company's market cap stands at $281.1 million. </li>
<li>Avanos Medical (NYSE:AVNS) shares fell 18.34% to $11.0. The market value of their outstanding shares is at $619.6 million. </li>
<li>Kairos Pharma (AMEX:KAPA) shares declined by 10.12% to $0.6. The market value of their outstanding shares is at $13.8 million. </li>
<li>ProMIS Neurosciences (NASDAQ:PMN) stock fell 8.69% to $12.83. The company's market cap stands at $30.2 million. </li>
<li>Biofrontera (NASDAQ:BFRI) stock decreased by 8.1% to $0.82. The market value of their outstanding shares is at $10.4 million. </li>
<li>TuHURA Biosciences (NASDAQ:HURA) shares declined by 7.15% to $0.48. The market value of their outstanding shares is at $29.3 million. 
See Also: www.benzinga.com/money/best-healthcare-stocks/</li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

In Tuesday's pre-market session, Liminatus Pharma (NASDAQ:LIMN) saw a significant gain of 28.5%, reaching $0.73, while CDT Equity (NASDAQ:CDT) rose by 15.31% to $1.28. DaVita (NYSE:DVA) increased by 10.63% to $123.02 following its Q4 earnings report. Other gainers included GT Biopharma (NASDAQ:GTBP) and Evotec (NASDAQ:EVO). Conversely, Armata Pharmaceuticals (AMEX:ARMP) dropped 28.4% to $5.54, and Avanos Medical (NYSE:AVNS) fell 18.34% to $11.0. Other notable losers included Kairos Pharma (AMEX:KAPA) and ProMIS Neurosciences (NASDAQ:PMN).

benzinga_article

CDT Equity

Evotec SE

iShares Global Healthcare

VanEck Biotech ETF

GT Biopharma

Invesco Nasdaq Biotechnology ETF

iShares US Pharma

iShares Genomics Immunology and Healthcare ETF

VG Health

SPDR S&P Biotech

Liminatus Pharma

iShares Biotechnology ETF

ALPS Medical Breakthrough

Avanos Medical

iShares US Healthcare Providers

Alto Neuroscience

DaVita

SPDR S&P Health

Invesco Biotechnology & Genome ETF

iShares US Medical Devices

Ark Genomic Revolution ETF

Proshares Ultra Nasdaq Biotech

First Trust NYSE Arca Biotech Index Fd

Health Care Select Sector SPDR

12 Health Care Stocks Moving In Tuesday's Pre-Market Session